Machine Learning Algorithm for Nanomedicine: AI Curated Nanocarriers for Cancer Treatment

Area of Science:

• Oncology
• Nanotechnology
• Artificial Intelligence

Background:

• Cancer's genetic variability complicates effective therapy development.
• Nanoparticle (NP) drug delivery systems (DDSs) offer potential for targeted cancer treatment.
• Integrating AI can overcome challenges in NP design and drug delivery.

Purpose of the Study:

• To review the integration of AI-driven methodologies in nanoparticle design for cancer therapy.
• To elucidate how AI optimizes drug delivery systems (DDSs) for enhanced cancer treatment.
• To highlight AI's role in developing next-generation smart therapeutics.

Main Methods:

• Utilizing AI predictive analytics for rational nanocarrier design.
• Employing machine learning (ML) models to accelerate NP fabrication and simulate tumor dynamics.
• Leveraging AI platforms (e.g., EVOnano) to simulate in silico tumor microenvironments.

Main Results:

• AI enhances nanocarrier design, improving drug bioavailability, pharmacokinetics, and tumor penetration.
• ML models accelerate NP fabrication and enable real-time simulation of drug release kinetics.
• AI-assisted nanomedicine demonstrates potential for enhanced tumor specificity and reduced systemic toxicity.

Conclusions:

• AI-assisted nanomedicine represents a paradigm shift in cancer treatment.
• This approach facilitates the development of patient-tailored, data-driven precision therapeutics.
• Interdisciplinary advances are needed to address challenges like scalability and biological heterogeneity.